Secondary failure rates of measles vaccines: A metaanalysis of published studies

Pediatric Infectious Disease Journal

Volumn 15, Issue 1, 1996, Pages 62-66

  Anders, Jennifer F ^a   Jacobson, Robert M ^a,b   Poland, Gregory A ^a   Jacobsen, Steven J ^a   Wollan, Peter C ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

immunization; Measles; metaanalysis; vaccine; vaccine failure

Indexed keywords

MEASLES VACCINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EPIDEMIC; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; META ANALYSIS; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT OUTCOME;

CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; MEASLES; MEASLES VACCINE; TREATMENT FAILURE; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 0030048783     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199601000-00014     Document Type: Article

References (24)

1. Centers for Disease Control. Elimination of indigenous measles: United States. MMWR 1982;31:517-9.
2. Centers for Disease Control. Measles: United States, 1990. MMWR 1991;40:369-72.
3. Markowitz L, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990;9:101-10.
4. Mathias RG, Meekison WG, Arcand TA, Schechter MT. The role of secondary vaccine failures in measles outbreaks. Am J Public Health 1989;79:475-8.
5. Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Martiner EA, eds. Vaccines. 2nd ed. Philadelphia: Saunders, 1994:229-76.
6. Rosenthal R. Meta-analytic procedures for social research. Beverly Hills, CA: Sage Publications, 1984.
7. Rauh LW, Schmidt R. Measles immunization with killed virus vaccine. Am J Dis Child 1965;109:232-7.
8. Lee MS, King CC, Jean JY, et al. Seroepidemiology and evaluation of passive surveillance during 1988-89 measles outbreak in Taiwan. Int J Epidemiol 1992;21:1165-74.
9. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162:1036-42.
10. Krugman SL, Giles JP, Jacobs AM. Studies on an attenuated measles-virus vaccine: VI. Clinical, antigenic, and prophylactic effects of vaccine in institutionalized children. N Engl J Med 1960;263:174-7.
11. Lepow ML, Nankervis GA. Eight-year serologic evaluation of Edmonston live measles vaccine. J Pediatr 1969;75:407-11.
12. Isomura S, Morishima T, Nishikawa K, et al. A long-term follow up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine. Biken J 1986;29:19-26.
13. Stokes J, Hilleman MR, Weibel RE, Buynak EB, Halenda R, Goldner H. Efficacy of live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med 1961;265:507-13.
14. Matson DO, Byington C, Canfield M, Albrecht P, Feigin RD. Investigation of a measles outbreak in a fully vaccinated school population, including serum studies before and after revaccination. Pediatr Infect Dis J 1993;12:292-9.
15. Gustafson T, Lievens AW, Brunell PA, Moellenberg RG, Buttery CM, Sehulster LM. Measles outbreak in a fully vaccinated secondary-school population. N Engl J Med 1987;316:771-4.
16. Centers for Disease Control. General recommendations on immunization. MMWR 1989;38:205-27.
17. Katz S. Measles in the United States: 1989 and 1990. Adv Pediatr Infect Dis 1991;679-90.
18. Johnson CE, Nalin DR, Chui LW, Whitwell J, Marusyk RG, Kumar ML. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Pediatrics 1994;6:939-44.
19. Cohn ML, Robinson ED, Faerber M, et al. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults. Pediatr Infect Dis J 1994;13:34-8.
20. Dai B, Chen Z, Liu Q, et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejian Province, China. Bull World Health Organ 1991;69:415-23.
21. Hayden GF. Measles vaccine failure: a survey of causes and means of prevention. Clin Pediatr 1979;18:155-67.
22. Pedersen IR, Mordhorst CH, Glikmann G, von Magnus H. Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. Vaccine 1989;7:345-8.
23. Cherry JD, Feigin RD, Shackelford PG, Hinthorn DR, Schmidt RR. A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr 1973;82:802-8.
24. Edmonson, M, Adiss DG, McPherson JT, Berg JL, Circo S, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990;263:2467-71.